AstraZeneca
profiles of and demonstrate stability of linker in platform and support dosing | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
September 2024
Slide
40 of 55
Related slides by other companies
Chimerix
Investor Presentation
August 2023
dose intensification expected to enhance duration of therapeutic exposure consecutive day dosing may increase therapeutic response phase trial data suggest a therapeutic and safe exposure possible with twice daily three times weekly dosing incubation time hours | Chimerix
Lion Electric
Investor Presentation
August 2023
technical specifications weight rating capacity maximum torque ranges up to miles level battery capacities charging type level level ill hours level ill charging time charging time hours lion electric | Lion Electric
Ocuphire Pharma
Results
March 2022
mean time to return to overall study eye fellow eye | Ocuphire Pharma
Flutter
Investor Day
September 2021
enhanced sustained our advantage during unprecedented growth | Flutter
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Results
February 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io